HempFusion Exceeds New Store Targets for the
Year, Products Now Available Across 18,000 Retail Locations
HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF)
(FWB:8OO) (“HempFusion” or the “Company”), a leading health and
wellness company offering premium probiotic supplements and
products containing CBD, is pleased to announce that another Top 15
US supermarket chain has launched HempFusion products in the
Southeast United States. HempFusion’s OTC (Over-the-Counter)) Pain
Relief Cream will be added to approximately 400 stores and
HempFusion’s Ingestible and Topical CBD products will now be
available in 75 targeted stores.
“This new Top 15 US grocery retailer builds upon our recent
announcements of launching our ingestible and topical CBD products
at a major Arizona grocery chain as well as the four SKUs our
Sagely Naturals division launched inside a Top 10 publicly listed
US Food, Drug & Mass (FDM) retailer,” said Jason Mitchell,
N.D., HempFusion‘s Co-Founder and Chief Executive Officer.
“Increasingly, retail grocery chains are investing in bringing
established health and wellness brands to consumers. Since the
beginning of 2021, HempFusion, and its family of brands, has grown
the number of doors for our products from approximately 15,000
locations to over 18,000 locations, establishing the Company as a
leading health and wellness brand across our multi-channel strategy
including the FDM channel. Our recent guidance to the market stated
that we would launch 2,000 more locations before the end of 2021
and we have already exceeded that target with more than 3,000 new
locations to date and growing,” continued Dr. Mitchell.
HempFusion is the first brand in this Southeastern United States
grocery retailer to be on-shelf in the analgesic section with an
OTC Pain Relief cream featuring menthol 1.75% and broad-spectrum
hemp derived CBD. The skin nourishing cream will be available in
approximately 400 stores.
Twelve additional SKUs of HempFusion’s Ingestibles including
USDA Certified Organic Tinctures, Gummies, Sleep and Stress Support
Capsules, and a variety of Topicals including Eczema Relief Cream
and Pain Relief Balm, will be merchandised on CBD fixtures at
nearly 100 stores.
ABOUT HEMPFUSION
One of a select few CBD companies who are today fully prepared
to meet or exceed expected FDA guidance, HempFusion Wellness Inc.
is a leading health and wellness company whose family of premium
consumer brands include HempFusion™, Sagely Naturals™,
Apothecanna™, and Probulin Probiotics™, one of the fastest-growing
probiotics companies in the United States according to SPINs
reported data.
Utilizing the power of whole-food hemp nutrition, the HempFusion
family of brands’ product portfolio comprises 112 SKUs including
USDA Organic Certified Tinctures, proprietary FDA Drug Listed
Over-The-Counter (OTC) Topicals, probiotic supplements and skin
care products, a Doctor/Practitioner line, a White Label division
and more. With a strong focus on research and development,
HempFusion Wellness has 43 products under development.
Available from more than 18,000 US retail locations across all
50 states, HempFusion Wellness products are also available in
China, Mexico, Ireland, United Kingdom, United Arab Emirates, South
Korea and Canada and may be purchased online from each brand’s
website, The Probulin Store on Amazon.com, Alibaba’s Tmall.com, the
world’s largest cross-border online marketplace, and a multitude of
additional e-commerce sites.
For more information, visit www.hempfusion.com. Follow
HempFusion on Twitter, Facebook and Instagram.
FORWARD-LOOKING STATEMENTS
This news release contains forward-looking statements and
forward-looking information within the meaning of Canadian
securities legislation (collectively, “forward-looking
statements“) that relate to HempFusion’s current expectations
and views of future events. Any statements that express, or involve
discussions as to, expectations, beliefs, plans, objectives,
assumptions or future events or performance (often, but not always,
through the use of words or phrases such as “will likely result”,
“are expected to”, “expects”, “will continue”, “is anticipated”,
“anticipates”, “believes”, “estimated”, “intends”, “plans”,
“forecast”, “projection”, “strategy”, “objective” and “outlook”)
are not historical facts and may be forward-looking statements and
may involve estimates, assumptions and uncertainties which could
cause actual results or outcomes to differ materially from those
expressed in such forward-looking statements. No assurance can be
given that these expectations will prove to be correct and such
forward-looking statements included in this news release should not
be unduly relied upon. These statements speak only as of the date
of this news release. In particular and without limitation, this
news release contains forward-looking statements relating to
expansion of the Company’s retail footprint and the Company’s other
plans, focus and objectives.
Forward-looking statements are based on a number of assumptions
and are subject to a number of risks and uncertainties, many of
which are beyond HempFusion’s control, which could cause actual
results and events to differ materially from those that are
disclosed in or implied by such forward-looking statements. Such
risks and uncertainties include, but are not limited to, the impact
and progression of the COVID-19 pandemic and other factors set
forth under “Cautionary Note Regarding Forward-Looking Statements”
and “Risk Factors” in the annual information form of the Company
dated March 31, 2021, and available under the Company’s profile on
SEDAR at www.sedar.com. HempFusion undertakes no obligation to
update or revise any forward-looking statements, whether as a
result of new information, future events or otherwise, except as
may be required by law. New factors emerge from time to time, and
it is not possible for HempFusion to predict all of them or assess
the impact of each such factor or the extent to which any factor,
or combination of factors, may cause results to differ materially
from those contained in any forward-looking statement. Any
forward-looking statements contained in this news release are
expressly qualified in their entirety by this cautionary
statement.
Neither the TSX nor its Regulation Services Provider (as that
term is defined in the policies of the TSX) accepts responsibility
for the adequacy or accuracy of this release.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20211104005220/en/
Investor Relations: Eric Balshin +1 437-826-9911
eric@sophiccapital.com
Company Contact: Jason Mitchell, N.D. Chief Executive Officer
and Director ir@hempfusion.com
HempFusion Wellness (TSX:CBD.U)
Historical Stock Chart
From Mar 2024 to Apr 2024
HempFusion Wellness (TSX:CBD.U)
Historical Stock Chart
From Apr 2023 to Apr 2024
